Marilyn Schapira, MD, MPH, Professor of Medicine, in the Division of General Internal Medicine has been appointed Co-Leader of the Abramson Cancer Center’s Cancer Control Program. Dr. Schapira will join Dr. Katherine (Kate) Nathanson as Co-Leader effective January 1, 2012. Dr. Schapira is an internationally recognized leader in the area of risk communication and medical decision making with an emphasis in the area of cancer communication. Her current research focuses on developing a new measure of health numeracy for use in the context of cancer care. Dr. Schapira’s work in the area of judgment and decision making addresses how to effectively communicate risk and uncertainty in medical outcomes to patients, physicians, the public, and policy makers.
Dr. Schapira received her MD and MPH from University of Michigan, Ann Arbor and completed an internship in Internal Medicine at Emory University and a residency in Internal Medicine at the University of North Carolina, Greensboro. Dr. Schapira completed a fellowship in General Internal Medicine at Duke University and the Medical College of Wisconsin. Dr. Schapira joined the faculty of the Medical College of Wisconsin as an Assistant Professor where she was promoted to Associate Professor and Professor and joined the Penn faculty as Professor of Medicine in 2011.
Dr. Schapira is the immediate past president of the Society for Medical Decision Making, serves on the editorial board of the Journal of Medical Decision Making and currently reviews for the Journal of General Internal Medicine and the Journal of Health Communication. She is a Fellow of the American College of Physicians has served several review boards including the NCI Health Services Organization and Delivery Study Section and the Technical Expert Panel, AHRQ Health Literacy Interventions and Outcomes: Updated Systematic Review. Dr. Schapira is a 2011 graduate of the Executive Leadership in Academic Medicine (ELAM) Fellowship program.
Please join us in welcoming Marilyn as she takes on her new role within the Abramson Cancer Center.